Comparison of PD-L1 Immunostain Concordance of SP263 and SP142 Across Different Tumor Types

被引：0
|
作者：
Nakasaki, Manando [1 ]
Fadare, Oluwole [1 ]
Patel, Sandip [1 ]
Hansel, Donna [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2140
引用
收藏
页码：532A / 532A
页数：1
相关论文
共 50 条
  • [21] Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types
    Maule, Jake G.
    Clinton, Lani K.
    Graf, Ryon P.
    Xiao, Jinpeng
    Oxnard, Geoffrey R.
    Ross, Jeffrey S.
    Huang, Richard S. P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [22] Pitfalls of PD-L1 Immunohistochemistry: A Comparison of 22C3 and SP263 antibodies Across Laboratories and Pathologists
    Wilberger, Adam
    Aisner, Dara
    Merrick, Daniel T.
    MODERN PATHOLOGY, 2018, 31 : 756 - 757
  • [23] Pitfalls of PD-L1 Immunohistochemistry: A Comparison of 22C3 and SP263 antibodies Across Laboratories and Pathologists
    Wilberger, Adam
    Aisner, Dara
    Merrick, Daniel T.
    LABORATORY INVESTIGATION, 2018, 98 : 756 - 757
  • [24] PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
    Yoon Jin Cha
    Dooreh Kim
    Soong June Bae
    Sung Gwe Ahn
    Joon Jeong
    Hye Sun Lee
    Soyoung Jeon
    Tae-Kyung Yoo
    Woo-Chan Park
    Chang Ik Yoon
    Scientific Reports, 11
  • [25] PD-L1 Expression in Metaplastic Breast Carcinoma (MBC) Using PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical (IHC) Assays
    Grabenstetter, Anne
    Jungbluth, Achim
    Frosina, Denise
    Hoda, Raza
    Weigelt, Britta
    Reis-Filho, Jorge
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark
    Brogi, Edi
    Wen, Hannah
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 159 - 160
  • [26] PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
    Cha, Yoon Jin
    Kim, Dooreh
    Bae, Soong June
    Ahn, Sung Gwe
    Jeong, Joon
    Lee, Hye Sun
    Jeon, Soyoung
    Yoo, Tae-Kyung
    Park, Woo-Chan
    Yoon, Chang Ik
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] PD-L1 Expression in Metaplastic Breast Carcinoma (MBC) Using PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical (IHC) Assays
    Grabenstetter, Anne
    Jungbluth, Achim
    Frosina, Denise
    Hoda, Raza
    Weigelt, Britta
    Reis-Filho, Jorge
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark
    Brogi, Edi
    Wen, Hannah
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 159 - 160
  • [28] SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
    Pang, Jia-Min B.
    Castles, Belinda
    Byrne, David J.
    Button, Peter
    Hendry, Shona
    Lakhani, Sunil R.
    Sivasubramaniam, Vanathi
    Cooper, Wendy A.
    Armes, Jane
    Millar, Ewan K. A.
    Raymond, Wendy
    Roberts-Thomson, Samuel
    Kumar, Beena
    Burr, Marian
    Selinger, Christina
    Harvey, Kate
    Chan, Charles
    Beith, Jane
    Clouston, David
    O'Toole, Sandra A.
    Fox, Stephen B.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (08) : 1108 - 1117
  • [29] Interobserver Variation of PD-L1 (SP142) Immunohistochemistry Interpretation in Breast Carcinoma
    Hoda, Raza
    Brogi, Edi
    D'Alfonso, Timothy
    Grabenstetter, Anne
    Giri, Dilip
    Hanna, Matthew
    Kuba, M. Gabriela
    Murray, Melissa
    Vallejo, Christina
    Zhang, Hong
    Reis-Filho, Jorge
    Wen, Hannah
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 173 - 175
  • [30] Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab
    Vennapusa, Bharathi
    Baker, Brian
    Kowanetz, Marcin
    Boone, Jennifer
    Menzl, Ina
    Bruey, Jean-Marie
    Fine, Gregg
    Mariathasan, Sanjeev
    McCaffery, Ian
    Mocci, Simonetta
    Rost, Sandra
    Smith, Dustin
    Dennis, Eslie
    Tang, Szu-Yu
    Damadzadeh, Bita
    Walker, Espen
    Hegde, Priti S.
    Williams, J. Andrew
    Koeppen, Hartmut
    Boyd, Zachary
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (02) : 92 - 100
12345